Priority dilemmas in psoriasis care and visions of a future care in a group of administrators, politicians and professionals in northern Sweden

Decision makers’ experiences of prioritisation and views about how to finance healthcare costs

“…The existing guidelines concerning prioritisation decisions issued by the Swedish Parliamentary Priorities Commission were not referred to by the physicians. Uttjek et al [14] found that there ought to be concrete statements in official documents about the prevailing views on which the priority decisions are based. Moreover, the public should be informed about the content of such documents [14].…”

“…Uttjek et al [14] found that there ought to be concrete statements in official documents about the prevailing views on which the priority decisions are based. Moreover, the public should be informed about the content of such documents [14]. The National Centre for Priority Setting in Healthcare and the Swedish National Board of Health and Welfare have presented a…”

The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis – an introduction

“…Although most patients are cared for in the community, some recalcitrant cases require inpatient care and incur significant costs 14,15 . Internationally, demands upon dermatology specialist services continue to escalate [16][17][18][19][20] , increasing outpatient referrals, pressure and waiting times for specialist consultations. In 2005 there were more GP referrals to dermatology clinics in the UK than to all other medical specialties combined 21 and in England now there are more than 9 million referrals annually 22 .…”